中药口服结合舒利迭吸入治疗慢性阻塞性肺疾病稳定期的疗效观察

目的 探讨中药口服结合舒利迭吸入治疗慢性阻塞性肺疾病稳定期疗效.方法 选取慢性阻塞性肺疾病稳定期患者96例,随机平均分为两组,对照组采取舒利迭吸入治疗,观察组在此基础上加用健脾补肺汤口服,比较两组临床疗效.结果 观察组治疗后FEV1、FEV1/FVC明显提高,治疗后与对照组比较差异显著（P＜0.01）,治疗后血气分析与对照组比较有显著性差异（P＜0.01）;治疗总有效率为95.8％,对照组为81.3％,两组比较有显著性差异（P＜0.05）.结论 中药口服结合舒利迭吸入治疗慢性阻塞性肺疾病稳定期效果显著,可有效改善肺功能,改善血气指标.

Efficacy Observation of Oral Medicine Combined Seretide Inhalation Treatment of Chronic Obstructive Pulmonary Disease Stabilization Period

Objective To investigate the effect of oral medicine combined seretide inhalation treatment of chronic obstructive pulmonary disease stabilization period. Methods 96 cases with stable chronic obstructive pulmonary disease were selected, and were randomly divided into two groups. The control group were given seretide inhalation for treatment, and the observation group were given oral spleen and lungs soup for treatment on this basis. Clinical efficacy of two groups was compared. Results FEV1, FEV1/FVC of the observation group after treatment improved significantly, with significant difference between the control group after treatment （P 〈 O. O1 ）. After treatment, PO_2 and PaCO_2 compared with control group were significantly different （ P 〈 O. O1 ）. The total effective rate was 95.8%, the control group was g 1.3 %, and the difference was also statistically significant （ P 〈 0.05 ）. Conclusion The effect of oral medicine combined seretide inhala- tion treatment of chronic obstructive pulmonary disease stabilization period is significant, and can effectively improve lung function.